Cargando…

Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice

MitoTEMPO, a mitochondrial antioxidant, has protective effects on liver-related diseases. However, the role of MitoTEMPO on nonalcoholic fatty liver disease (NAFLD) and its possible mechanisms are largely unknown. Here, we investigated the effects of MitoTEMPO on NAFLD using high fat diet- (HFD-) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiayuan, Zheng, Li, Mo, Juanfen, Yao, Xiujuan, Fan, Chenliang, Bao, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414374/ https://www.ncbi.nlm.nih.gov/pubmed/32802885 http://dx.doi.org/10.1155/2020/9329427

Ejemplares similares

Addition of MitoTEMPO to the maturation medium improves in vitro maturation competence of bovine oocytes
por: Yousefian, Iman, et al.
Publicado: (2022)

Effect of mitoTEMPO on Redox Reactions in Different Body Compartments upon Endotoxemia in Rats
por: Weidinger, Adelheid, et al.
Publicado: (2023)

Mitochondria Specific Antioxidant, MitoTEMPO, Modulates Cd Uptake and Oxidative Response of Soybean Seedlings
por: Fayazipour, Dalir, et al.
Publicado: (2022)

Reversal of Doxorubicin-Induced Bone Loss and Mineralization by Supplementation of Resveratrol and MitoTEMPO in the Early Development of Sparus aurata
por: Poudel, Sunil, et al.
Publicado: (2022)

763 The Cardioprotective Effects of Sildenafil, PJ34, MitoTEMPO, and ZLN005 in the Early After Burn Injury
por: Radhakrishnan, Ravi, et al.
Publicado: (2023)

Mitochondria-Targeted Antioxidants MitoQ and MitoTEMPO Do Not Influence BRAF-Driven Malignant Melanoma and KRAS-Driven Lung Cancer Progression in Mice
por: Le Gal, Kristell, et al.
Publicado: (2021)

MitoTEMPO Prevents Oxalate Induced Injury in NRK-52E Cells via Inhibiting Mitochondrial Dysfunction and Modulating Oxidative Stress
por: Zhang, Jiaqiao, et al.
Publicado: (2017)

Pretreatment of Diabetic Adipose-derived Stem Cells with mitoTEMPO Reverses their Defective Proangiogenic Function in Diabetic Mice with Critical Limb Ischemia
por: Lian, Kun, et al.
Publicado: (2019)

Systemic Effects of mitoTEMPO upon Lipopolysaccharide Challenge Are Due to Its Antioxidant Part, While Local Effects in the Lung Are Due to Triphenylphosphonium
por: Weidinger, Adelheid, et al.
Publicado: (2022)

Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis
por: Rademann, Pia, et al.
Publicado: (2017)

Mito-TEMPO Alleviates Renal Fibrosis by Reducing Inflammation, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress
por: Liu, Yuqing, et al.
Publicado: (2018)

Polydatin Inhibits Adipose Tissue Inflammation and Ameliorates Lipid Metabolism in High-Fat-Fed Mice
por: Zheng, Li, et al.
Publicado: (2019)

Mito-TEMPO improves development competence by reducing superoxide in preimplantation porcine embryos
por: Yang, Seul-Gi, et al.
Publicado: (2018)

Mito-Tempo improves acrosome integrity of frozen-thawed epididymal spermatozoa in tomcats
por: Ali Hassan, Hiba, et al.
Publicado: (2023)

Hepatoprotective Effect of Mitochondria-Targeted Antioxidant Mito-TEMPO against Lipopolysaccharide-Induced Liver Injury in Mouse
por: Wang, Peng-Fei, et al.
Publicado: (2022)

Oltre il mito: Lamarck e le scienze naturali del suo tempo
por: di Gregorio, Mario A.
Publicado: (1986)

Cardioprotective potential of mitochondria-targeted antioxidant, mito-TEMPO, in 5-fluorouracil-induced cardiotoxicity
por: Tambe, Prasad Kisan, et al.
Publicado: (2023)

P234 MYELOID-DERIVED SUPPRESSOR CELLS AND DENDRITIC CELLS FOR IMPAIRED RESPONSE TO VACCINE IN MICE WITH NONALCOHOLIC FATTY LIVER DISEASE
por: Akbar, S.M.F., et al.
Publicado: (2014)

The Late-Stage Protective Effect of Mito-TEMPO against Acetaminophen-Induced Hepatotoxicity in Mouse and Three-Dimensional Cell Culture Models
por: Abdullah-Al-Shoeb, Mohammad, et al.
Publicado: (2020)

Mito-TEMPO mitigates 5-fluorouracil-induced intestinal injury via attenuating mitochondrial oxidative stress, inflammation, and apoptosis: an in vivo study
por: Tambe, Prasad Kisan, et al.
Publicado: (2023)

The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities
por: Mo, Juanfen, et al.
Publicado: (2021)

I nomi del tempo: la seconda rivoluzione scientifica e il mito della freccia temporale
por: Bellone, Enrico
Publicado: (1989)

Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease
por: Wang, Fang, et al.
Publicado: (2019)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice
por: Ding, Jian, et al.
Publicado: (2023)

Protective effect of whey proteins against nonalcoholic fatty liver in rats
por: Hamad, Essam M, et al.
Publicado: (2011)

Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease
por: Yang, Weijia, et al.
Publicado: (2019)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2021)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The Protective Effect of Myristica fragrans Houtt. Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease
por: Zhao, Wenyu, et al.
Publicado: (2020)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
por: Menghini, Rossella, et al.
Publicado: (2012)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
por: Puengel, Tobias, et al.
Publicado: (2022)

Hepatic inflammation: an important target for biomarker development in nonalcoholic fatty liver disease
por: Khan, Hiba, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression
por: Liu, Lin, et al.
Publicado: (2022)

Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
por: van Geffen, Chiel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i2ibvo2cfvfmvb8sb9ujrms3gk